TABLE 1-A3.
Consumption of most frequently used agents.
| Most used antibiotics | Indication |
||
|---|---|---|---|
| Prophylaxis (95% CI) | Empiric (95% CI) | Targeted (95% CI) | |
| DDD per 1000 patient days in the baseline stage | |||
| Amoxicillin/clavulanic acid | 28.14 (21.66–34.63) | 170.69 (147.14–194.24) | 28.26 (19.21–37.31) |
| Piperacillin/tazobactam | - | 147.57 (61.86–233.29) | 22.91 (15.07–30.74) |
| Fluconazole | 52.08 | 83.14 (49.14–117.15) | - |
| Metronidazole | 0.15 | 19.46 (7.35–31.57) | 3.87 (1.73–6.00) |
| Cefazolin | 7.99 (6.75–9.24) | - | - |
| DDD per 100 0 patient days in the ASP stage | |||
| Amoxicillin/clavulanic acid | 12.41 (8.45–16.38) | 107.05 (89.76–124.33) | 14.05 (7.12–20.98) |
| Piperacillin/tazobactam | - | 90.16 (79.30–100.93) | 27.68 (21.54–33.83) |
| Fluconazole | 12.13 (9.32–14.93) | 79.53 (47.52–111.54) | 23.54 (2.49–44.58) |
| Ertapenem | - | 5.35 (3.58–7.11) | 21.04 (13.97–28.11) |
| Cefazolin | 11.06 (6.25–15.87) | - | - |
ASP, antibiotic stewardship programmes; CI, confidence interval, DDD, defined daily doses.